Guangdong Hybribio Biotech Co.,Ltd. (SHE:300639)
5.98
+0.09 (1.53%)
Aug 11, 2026, 3:04 PM CST
SHE:300639 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 661.41 | 669.64 | 815.53 | 1,104 | 5,597 | 2,673 |
Revenue Growth | -13.71% | -17.89% | -26.16% | -80.27% | 109.39% | 97.34% |
Gross Profit Gross Profit Growth | 282.13 | 292.28 | 375.18 | 662.35 | 3,790 | 1,808 |
Operating Income Operating Income Growth | -171.83 | -188.4 | -810.23 | -5.62 | 2,424 | 1,046 |
Net Income Net Income Growth | -106.43 | -130.94 | -654.88 | 140.47 | 1,726 | 852.16 |
Earnings Per Share EPS Growth | -0.17 | -0.21 | -1.02 | - | 2.62 | 1.29 |
EPS Growth | - | - | - | - | 102.58% | 118.80% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
in Vitro Diagnostic Reagents, Supporting Instruments and Consumables in Vitro Diagnostic Reagents, Supporting Instruments and Consumables Growth | 549.6 |
Medical Testing Services Medical Testing Services Growth | 267.26 |
Medical Services Medical Services Growth | 27.49 |
Offset of Business Segment Offset of Business Segment Growth | -174.71 |
Total Total Growth | 669.64 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 950.87 | 1,039 | 963.27 | 1,072 | 1,412 | 1,199 |
Total Debt Total Debt Growth | 87.31 | 89.56 | 87.51 | 56.65 | 139.49 | 185.15 |
Net Cash (Debt) Net Cash Growth | 863.55 | 949.15 | 875.76 | 1,015 | 1,272 | 1,014 |
Net Cash Growth | 55.35% | 8.38% | -13.75% | -20.20% | 25.48% | -13.74% |
Net Cash Per Share Net Cash Per Share Growth | 1.38 | 1.52 | 1.36 | - | 1.93 | 1.54 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 319.64 | 341.61 | 78.78 | 319.6 | 1,309 | 631.34 |
Capital Expenditures CapEx Growth | -94.65 | -92.39 | -148.33 | -385.32 | -734.37 | -641.07 |
Free Cash Flow Free Cash Flow Growth | 225 | 249.21 | -69.55 | -65.72 | 574.85 | -9.73 |
Free Cash Flow Growth | 224.15% | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 42.66% | 43.65% | 46.01% | 59.97% | 67.72% | 67.62% |
Operating Margin | -25.98% | -28.13% | -99.35% | -0.51% | 43.30% | 39.13% |
Pretax Margin | -19.38% | -25.29% | -102.14% | 3.33% | 38.02% | 39.55% |
Profit Margin | -16.09% | -19.55% | -80.30% | 12.72% | 30.84% | 31.88% |
FCF Margin | 34.02% | 37.22% | -8.53% | -5.95% | 10.27% | -0.36% |
| Fiscal Year | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Period Ending | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.065 | 0.233 | 0.155 |
Dividend Per Share Growth | -72.14% | 50.03% | 74.13% |
Dividend Yield | 0.70% | 2.15% | 1.24% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | - | - | 42.64 | 4.26 | 10.09 |
Forward PE | - | 18.89 | 24.20 | 23.95 | 4.88 | 12.96 |
P/FCF Ratio | 16.68 | 13.55 | - | - | 12.81 | - |
PS Ratio | 5.67 | 5.04 | 4.63 | 5.42 | 1.32 | 3.22 |